US patent addition on Sterilox Systems granted
US-based life sciences company PuriCore has been granted an additional patent for its Sterilox system from the US Patent and Trademark Office.
The company, which focuses on the development and commercialisation of antimicrobial technology, markets them in the US and UK as Sterilox Food Safety Systems and Sterilox Endoscopy Systems, respectively.
These systems produce hypochlorous acid at near neutral pH, the same safe and effective antimicrobial solution produced by the human body to fight infection.
The US Patent No. 7,303,660 is part of the same patent family as PuriCore’s previously issued US Patent No. 6,632,347, which covers an optimal process for operating PuriCore’s Systems to prepare its disinfection solutions.
“Together, these patents protect PuriCore's core technology and further verify its standing as a leader and innovator in the field of infection control,” said PuriCore ceo Greg Bosch. “We continue to expand our broad intellectual property portfolio focused on safe and effective antimicrobial solutions and devices for producing these solutions.”
PuriCore is headquartered in Malvern, Pennsylvania, with offices in Stafford, UK.